List of bibliographic references
Number of relevant bibliographic references: 46.
[20-40] [
0 - 20][
0 - 46][
40-45][
40-60]
| Ident. | Authors (with country if any) | Title |
|---|
| 000824 (2013) |
Philippe Huot [Canada] ; Susan H. Fox | The serotonergic system in motor and non-motor manifestations of Parkinson's disease. |
| 000828 (2013) |
Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Susan H. Fox ; Jonathan M. Brotchie | The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease. |
| 000835 (2013) |
James B. Koprich [Canada] ; Philippe Huot ; Susan H. Fox ; Keith Jarvie ; Anthony E. Lang ; Philip Seeman ; Jonathan M. Brotchie | The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques. |
| 000883 (2013) |
Lorraine V. Kalia [Canada] ; Jonathan M. Brotchie ; Susan H. Fox | Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials. |
| 000885 (2013) |
Susan H. Fox [Canada] | Non-dopaminergic treatments for motor control in Parkinson's disease. |
| 000972 (2013) |
Tiago A. Mestre [Canada] ; Mateusz Zurowski ; Susan H. Fox | 5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders. |
| 000A40 (2012) |
Philippe Huot [Canada] ; Tom H. Johnston ; James B. Koprich ; Ahmed Aman ; Susan H. Fox ; Jonathan M. Brotchie | L-745,870 reduces L-DOPA-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. |
| 000A53 (2012) |
Philippe Huot [Canada] ; Tom H. Johnston ; Naomi P. Visanji ; Tayyeba Darr ; Donna Pires ; Lili-Naz Hazrati ; Jonathan M. Brotchie ; Susan H. Fox | Increased levels of 5-HT1A receptor binding in ventral visual pathways in Parkinson's disease. |
| 000A84 (2012) |
Barbara S. Connolly [Canada] ; Susan H. Fox | Drug treatments for the neuropsychiatric complications of Parkinson's disease. |
| 000B16 (2012) |
Tom H. Johnston [Canada] ; Zak Millar ; Philippe Huot ; Keith Wagg ; Sherri Thiele ; Danielle Salomonczyk ; Christopher J. Yong-Kee ; Michael N. Gandy ; Matthew Mcildowie ; Katie D. Lewis ; Jordi Gomez-Ramirez ; Joohyung Lee ; Susan H. Fox ; Mathew Martin-Iverson ; Joanne E. Nash ; Matthew J. Piggott ; Jonathan M. Brotchie | A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates. |
| 000B38 (2011) |
Philippe Huot [Canada] ; Susan H. Fox ; Jonathan M. Brotchie | The serotonergic system in Parkinson's disease. |
| 000B47 (2011) |
Susan H. Fox [Canada] ; Regina Katzenschlager ; Shen-Yang Lim ; Bernard Ravina ; Klaus Seppi ; Miguel Coelho ; Werner Poewe [Autriche] ; Olivier Rascol ; Christopher G. Goetz ; Cristina Sampaio | The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease. |
| 000B51 (2011) |
Pettarusp M. Wadia [Canada] ; Gamaliel Tan ; Renato P. Munhoz ; Susan H. Fox ; Stephen J. Lewis ; Anthony E. Lang | Surgical correction of kyphosis in patients with camptocormia due to Parkinson's disease: a retrospective evaluation. |
| 000C39 (2011) |
Philippe Huot [Canada] ; Susan H. Fox ; Adrian Newman-Tancredi ; Jonathan M. Brotchie | Anatomically selective serotonergic type 1A and serotonergic type 2A therapies for Parkinson's disease: an approach to reducing dyskinesia without exacerbating parkinsonism? |
| 000C67 (2010) |
Susan H. Fox [Canada] ; Jonathan M. Brotchie | The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future. |
| 000C73 (2010) |
Benedicte Ballanger [Canada] ; Antonio P. Strafella ; Thilo Van Eimeren ; Mateusz Zurowski ; Pablo M. Rusjan ; Sylvain Houle ; Susan H. Fox | Serotonin 2A receptors and visual hallucinations in Parkinson disease. |
| 000C76 (2010) |
Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Mcildowie ; Matthew J. Piggott ; Jonathan M. Brotchie | Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease. |
| 000D95 (2009) |
Susan H. Fox [Canada] ; Rosalind Chuang ; Jonathan M. Brotchie | Serotonin and Parkinson's disease: On movement, mood, and madness. |
| 000E19 (2009) |
Shen-Yang Lim [Canada] ; Susan H. Fox ; Anthony E. Lang | Overview of the extranigral aspects of Parkinson disease. |
| 000F27 (2008) |
Susan H. Fox [Canada] ; Rosalind Chuang ; Jonathan M. Brotchie | Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy. |
| 000F32 (2008) |
Susan H. Fox [Canada] ; Jonathan M. Brotchie ; Anthony E. Lang | Non-dopaminergic treatments in development for Parkinson's disease. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "Susan H. Fox"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i \
-Sk "Susan H. Fox" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Checkpoint
|type= indexItem
|index= Author.i
|clé= Susan H. Fox
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
